SCHEMBL30351570

SCHEMBL30351570

O=C1c2c(F)ccc(N3CC4CC3CN4)c2CN1C1CCCNC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.43
▸ HTR2B P41595 5/20 0.42
▸ HTR2C P28335 4/20 0.42
▸ HTR2A P28223 1/20 0.39
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ HTR3E A5X5Y0 1/20 0.36
▸ HTR3B O95264 1/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ TMEM97 Q5BJF2 1/20 0.36
▸ HTR3D Q70Z44 1/20 0.36
▸ HTR3C Q8WXA8 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ MAP4K1 Q92918 3/20 0.34
▸ NTRK1 P04629 2/20 0.33
▸ MAP4K2 Q12851 1/20 0.33
▸ STK4 Q13043 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30351836 0.93 PARP1 (0.44) PARP1HTR2BHTR2CHTR2AIRAK4
SCHEMBL30352004 0.87 PARP1 (0.40) PARP1HTR2BHTR2CIRAK4HTR3E
SCHEMBL30352207 0.87 PARP1 (0.40) PARP1HTR2BHTR2CIRAK4HTR3E
SCHEMBL30351668 0.84 PARP1 (0.41) PARP1HTR2BHTR2CIRAK4HTR3E
SCHEMBL30351659 0.84 PARP1 (0.39) PARP1HTR2BHTR2CHTR2AIRAK4
SCHEMBL30352202 0.84 PARP1 (0.42) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30351966 0.82 PARP1 (0.44) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30351578 0.82 PARP1 (0.39) PARP1HTR2BHTR2CHTR2AIRAK4
SCHEMBL26132064 0.81 MAP4K1 (0.35) PARP1CHRNB2CHRNA4MAP4K1NTRK1
SCHEMBL30352306 0.80 PARP1 (0.41) PARP1HTR2BHTR2CHTR2AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066350-A1 CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS 标新生物医药科技(上海)有限公司 2023-04-27 — — WO claimed
Send feedback